[HTML][HTML] CC16 augmentation reduces exaggerated COPD-like disease in Cc16-deficient mice

J Rojas-Quintero, ME Laucho-Contreras, X Wang… - JCI insight, 2023 - ncbi.nlm.nih.gov
Abstract Low Club Cell 16 kDa protein (CC16) plasma levels are linked to accelerated lung
function decline in patients with chronic obstructive pulmonary disease (COPD). Cigarette …

The role of eosinophil-derived neurotoxin and vascular endothelial growth factor in the pathogenesis of eosinophilic asthma

M Tota, J Łacwik, J Laska, Ł Sędek, K Gomułka - Cells, 2023 - mdpi.com
Asthma is a chronic complex pulmonary disease characterized by airway inflammation,
remodeling, and hyperresponsiveness. Vascular endothelial growth factor (VEGF) and …

Alveolar epithelial and endothelial cell apoptosis in emphysema: what we know and what we need to know

MC Morissette, J Parent, J Milot - International journal of chronic …, 2009 - Taylor & Francis
Emphysema is mainly caused by cigarette smoking and is characterized by the loss of
alveolar integrity and an enlargement of the alveolar space. However, mechanisms involved …

Pulmonary vascular development goes awry in congenital lung abnormalities

H Kool, D Mous, D Tibboel, A de Klein… - … Research Part C …, 2014 - Wiley Online Library
Pulmonary vascular diseases of the newborn comprise a wide range of pathological
conditions with developmental abnormalities in the pulmonary vasculature. Clinically …

Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease–like phenotype in adiponectin-null mice: implications for therapy

K Nakanishi, Y Takeda, S Tetsumoto… - American journal of …, 2011 - atsjournals.org
Rationale: Chronic obstructive pulmonary disease is frequently complicated with
comorbidities, such as cardiovascular disease, osteoporosis, and body weight loss, but the …

[图书][B] Pulmonary circulation

AJ Peacock, R Naeije, LJ Rubin - 2010 - api.taylorfrancis.com
The consequences of disturbed function of the pulmonary circulation remain an enigma to
most clinicians. There is disturbance of pulmonary circulatory function in nearly all cardiac …

Vascular pathobiology of pulmonary hypertension

E Gallardo-Vara, A Ntokou, JM Dave, DG Jovin… - The Journal of Heart and …, 2023 - Elsevier
Pulmonary hypertension (PH), increased blood pressure in the pulmonary arteries, is a
morbid and lethal disease. PH is classified into several groups based on etiology, but …

[HTML][HTML] Proposed pathogenesis of diffuse alveolar hemorrhage in idiopathic pulmonary hemosiderosis

BK Saha, WH Chong, S Saha, A Aiman, A Bonnier - Lung, 2022 - Springer
Idiopathic pulmonary hemosiderosis (IPH) is a rare disease that causes diffuse alveolar
hemorrhage (DAH). The latest data suggests an immunologic origin of IPH, and a new …

Lung Disease Associated with α1-Antitrypsin Deficiency

RM Tuder, SM Janciauskiene… - Proceedings of the …, 2010 - atsjournals.org
α1-Antitrypsin (A1AT) is a polyvalent, acute-phase reactant with an extensive range of
biological functions that go beyond those usually linked to its antiprotease (serpin) activities …

[HTML][HTML] Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung

MJ Pajares, J Agorreta, M Larrayoz… - Journal of clinical …, 2012 - ncbi.nlm.nih.gov
Purpose Antiangiogenic therapies targeting the vascular endothelial growth factor (VEGF)
pathway have yielded more modest clinical benefit to patients with non–small-cell lung …